Search Results - "Carvidi, Alexander B."

Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30 by Hogan, Louise E, Vasquez, Joshua, Hobbs, Kristen S, Hanhauser, Emily, Aguilar-Rodriguez, Brandon, Hussien, Rajaa, Thanh, Cassandra, Gibson, Erica A, Carvidi, Alexander B, Smith, Louis C B, Khan, Shahzada, Trapecar, Martin, Sanjabi, Shomyseh, Somsouk, Ma, Stoddart, Cheryl A, Kuritzkes, Daniel R, Deeks, Steven G, Henrich, Timothy J

“…HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge…”
Get full text

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study by Deepak, Parakkal, Kim, Wooseob, Paley, Michael A, Yang, Monica, Carvidi, Alexander B, Demissie, Emanuel G, El-Qunni, Alia A, Haile, Alem, Huang, Katherine, Kinnett, Baylee, Liebeskind, Mariel J, Liu, Zhuoming, McMorrow, Lily E, Paez, Diana, Pawar, Niti, Perantie, Dana C, Schriefer, Rebecca E, Sides, Shannon E, Thapa, Mahima, Gergely, Maté, Abushamma, Suha, Akuse, Sewuese, Klebert, Michael, Mitchell, Lynne, Nix, Darren, Graf, Jonathan, Taylor, Kimberly E, Chahin, Salim, Ciorba, Matthew A, Katz, Patricia, Matloubian, Mehrdad, O'Halloran, Jane A, Presti, Rachel M, Wu, Gregory F, Whelan, Sean P J, Buchser, William J, Gensler, Lianne S, Nakamura, Mary C, Ellebedy, Ali H, Kim, Alfred H J

“…Patients with chronic inflammatory disease (CID) treated with immunosuppressive medications have increased risk for severe COVID-19. Although mRNA-based…”
Get full text

Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma by Wang, Chia-Ching, Thanh, Cassandra, Gibson, Erica A., Ball-Burack, Maya, Hogan, Louise E., Descours, Benjamin, Jones, Norman, Carvidi, Alexander B., Munter, Sadie, Bakkour, Sonia, Busch, Michael P., Milush, Jeffrey M., Deeks, Steven G., Henrich, Timothy J.

“…Key Points Anti-CD30 therapy for Hodgkin lymphoma led to transient loss of detectable CD4+ T-cell HIV RNA and a decrease in residual plasma viremia. Targeting…”
Get full text

Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES by Deepak, Parakkal, Kim, Wooseob, Paley, Michael, Yang, Monica, Burdess, Samantha, Carvidi, Alexander B., Demissie, Emanuel, El-Qunni, Alia A., Haile, Alem, Huang, Katherine, Escudero, Guadalupe Oliva, McMorrow, Lily E., Paez, Diana, Pawar, Niti, Perantie, Dana C., Schriefer, Rebecca E., Sides, Shannon E., Thapa, Mahima, Gergely, Maté, Akuse, Sewuese E., Klebert, Michael, Mitchell, Lynne, Nix, Billy D., Graf, Jonathan, Taylor, Kimberly E., Chahin, Salim, Ciorba, Matthew A., Katz, Patricia, Matloubian, Mehrdad, O'Halloran, Jane A., Presti, Rachel M., Wu, Gregory F., Gensler, Lianne S., Nakamura, Mary C., Ellebedy, Ali H., Kim, Alfred H.

Get full text

Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4.sup.+ T cells expressing CD30 by Hogan, Louise E, Vasquez, Joshua, Hobbs, Kristen S, Hanhauser, Emily, Aguilar-Rodriguez, Brandon, Hussien, Rajaa, Thanh, Cassandra, Gibson, Erica A, Carvidi, Alexander B, Smith, Louis C. B, Khan, Shahzada, Trapecar, Martin, Sanjabi, Shomyseh, Somsouk, Ma, Stoddart, Cheryl A, Kuritzkes, Daniel R, Deeks, Steven G, Henrich, Timothy J

“…HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge…”
Get full text